Arcellx Inc. Common Stock is a clinical-stage biotechnology company pioneering the development of novel cell therapies for patients with cancer and autoimmune diseases. With a unique play on cell signaling and expansion, their innovative platform has the potential to transform the treatment landscape.
Notification